Birchview Capital, LP Biodesix Inc Transaction History
Birchview Capital, LP
- $124 Million
- Q3 2025
A detailed history of Birchview Capital, LP transactions in Biodesix Inc stock. As of the latest transaction made, Birchview Capital, LP holds 286,804 shares of BDSX stock, worth $2.29 Million. This represents 1.72% of its overall portfolio holdings.
Number of Shares
286,804
Previous 5,736,113
95.0%
Holding current value
$2.29 Million
Previous $1.61 Million
33.0%
% of portfolio
1.72%
Previous 1.69%
Shares
14 transactions
Others Institutions Holding BDSX
# of Institutions
10Shares Held
1.14MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY416KShares$3.33 Million0.0% of portfolio
-
Cannell & Co. New York, NY206KShares$1.64 Million0.01% of portfolio
-
Allworth Financial LP99.3KShares$794,6480.0% of portfolio
-
Ajo Vista, LLC Boston, MA45.1KShares$360,9920.35% of portfolio
-
Cvi Holdings, LLC Wilmington, DE38.5KShares$308,2800.51% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $320M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...